Interplay of the quality of ciprofloxacin and antibiotic resistance in developing countries

D Sharma, RP Patel, STR Zaidi, MMR Sarker… - Frontiers in …, 2017 - frontiersin.org
Ciprofloxacin, a second generation broad spectrum fluoroquinolone, is active against both
Gram-positive and Gram-negative bacteria. Ciprofloxacin has a high oral bioavailability and …

Generic drugs: Review and experiences from South India

P Mathew - Journal of family medicine and primary care, 2015 - journals.lww.com
The cost of pharmaceuticals, as a percentage of total healthcare spending, has been rising
worldwide. This has resulted in strained national budgets and a high proportion of people …

Nutraceuticals and dietary supplements: balancing out the pros and cons

F Fernandes, M Carocho, MA Prieto, L Barros… - Food & Function, 2024 - pubs.rsc.org
While the market is full of different dietary supplements, in most countries, legislation is clear
and strict towards these products, with severe limitations on their health claims. Overall, the …

Assessment of current prescribing practices using World Health Organization core drug use and complementary indicators in selected rural community pharmacies in …

A Aravamuthan, M Arputhavanan… - … of pharmaceutical policy …, 2017 - Springer
Background Due to the lack of clear, comprehensive, and rational drug policy, the
production of pharmaceutical preparations in India is distorted for the most part. Indian …

Perceptions of the quality of generic medicines: implications for trust in public services within the local health system in Tumkur, India

PK Aivalli, MA Elias, MK Pati, S Bhanuprakash… - BMJ Global …, 2018 - gh.bmj.com
Introduction Generic medicines are an important policy option to reduce out-of-pocket
expenditure on medicines. However, negative perceptions of their quality affect utilisation …

Multimorbidity and out-of-pocket expenditure for medicines in China and India

DTV La, Y Zhao, P Arokiasamy, R Atun, S Mercer… - BMJ Global …, 2022 - gh.bmj.com
Introduction Using nationally representative survey data from China and India, this study
examined (1) the distribution and patterns of multimorbidity in relation to socioeconomic …

Analysis of issues of generic medicine supply chain using fuzzy AHP: a Pilot study of Indian public drug distribution scheme

D Kumar - International Journal of Pharmaceutical and Healthcare …, 2021 - emerald.com
Purpose Integrated supply chain in pharmaceutical industry requires organized planning
and modeling of each strategic element of pharmaceutical supply chain (PSC). The aim is to …

[HTML][HTML] Fluoroquinolone-resistant tuberculosis: implications in settings with weak healthcare systems

K Jabeen, S Shakoor, R Hasan - International Journal of Infectious …, 2015 - Elsevier
Fluoroquinolones (FQ) play an essential role in the treatment and control of multidrug-
resistant tuberculosis (MDR-TB). They are also being evaluated as part of newer regimens …

Catastrophic health expenditure on private sector pharmaceuticals: a cross-sectional analysis from the state of Odisha, India

A Haakenstad, A Kalita, B Bose… - Health Policy and …, 2022 - academic.oup.com
India has high rates of catastrophic health expenditure (CHE): 16% of Indian households
incur CHE. To understand why CHE is so high, we conducted an in-depth analysis in the …

[HTML][HTML] A cost analysis of the Jan Aushadhi scheme in India

K Mukherjee - International journal of health policy and …, 2017 - ncbi.nlm.nih.gov
Medicines constitute a substantial proportion of out-of-pocket (OOP) expenses in Indian
households. In order to address this issue, the Government of India launched the Jan …